Header Logo

Connection

CHRISTIE BALLANTYNE to Maximum Tolerated Dose

Back to Details
This is a "connection" page, showing publications CHRISTIE BALLANTYNE has written about Maximum Tolerated Dose.
CHRISTIE BALLANTYNE
Connection Strength
0.036
Maximum Tolerated Dose
  1. Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials). Am J Cardiol. 2018 04 15; 121(8):940-948.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.